OtherBASIC SCIENCE INVESTIGATIONS
Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate
Sara Eyal, Francisco S. Chung, Mark Muzi, Jeanne M. Link, David A. Mankoff, Amal Kaddoumi, Finbarr O'Sullivan, Mary F. Hebert and Jashvant D. Unadkat
Journal of Nuclear Medicine May 2009, 50 (5) 798-806; DOI: https://doi.org/10.2967/jnumed.108.059360
Sara Eyal
Francisco S. Chung
Mark Muzi
Jeanne M. Link
David A. Mankoff
Amal Kaddoumi
Finbarr O'Sullivan
Mary F. Hebert
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate
Sara Eyal, Francisco S. Chung, Mark Muzi, Jeanne M. Link, David A. Mankoff, Amal Kaddoumi, Finbarr O'Sullivan, Mary F. Hebert, Jashvant D. Unadkat
Journal of Nuclear Medicine May 2009, 50 (5) 798-806; DOI: 10.2967/jnumed.108.059360
Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate
Sara Eyal, Francisco S. Chung, Mark Muzi, Jeanne M. Link, David A. Mankoff, Amal Kaddoumi, Finbarr O'Sullivan, Mary F. Hebert, Jashvant D. Unadkat
Journal of Nuclear Medicine May 2009, 50 (5) 798-806; DOI: 10.2967/jnumed.108.059360
Jump to section
Related Articles
Cited By...
- Transplacental Pharmacokinetic Model of Digoxin Based on Ex Vivo Human Placental Perfusion Study
- Impact of P-Glycoprotein-Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates
- Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities
- Emerging Models of Drug Metabolism, Transporters, and Toxicity
- Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
- Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study
- Role of (Drug) Transporters in Imaging in Health and Disease
- Modeling Cyclosporine A Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition
- Developmental Changes in P-Glycoprotein Function in the Blood-Brain Barrier of Nonhuman Primates: PET Study with R-11C-Verapamil and 11C-Oseltamivir
- Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation